Codexis Inc - CDXS Earnings growth forecast for next year
Codexis, Inc. (CDXS) is implementing green chemistry principles by creating eco-friendly enzymes to reduce industrial waste. The projected growth rate of earnings per share confirms this potential, where the value of 25.90 serves as the current metric. Risks are linked to the dependency on the CodeEvolver platform and the inertia of long-term licensing agreements with pharmaceutical behemoths that provide the primary liquidity inflow.
CDXS (Codexis): analytical breakdowns and indicator data
- stock quotes and analyst forecast:
- issuer market value details:
- book capitalization indicators:
- debt and liquidity data:
Total Debt to Equity Ratio Codexis, Inc.|CDXS - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital Codexis Inc|CDXS - Company Total Debt|Debts to Book Capitalization Codexis, Inc.|CDXS - Company Long-Term Indebtedness|Company Current Liabilities Codexis, Inc.|Quick Liquidity codexis.com
- net income and valuation ratios data:
CDXS - Net Financial Result|Projected Future Earnings Codexis, Inc.|CDXS - Price to Earnings Multiple|Future Price to Earnings Codexis Inc|CDXS - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple Codexis, Inc.|CDXS - Operating profit EBITDA|Net earnings per share (EPS TTM) Codexis, Inc.|CDXS - Net earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months codexis.com|CDXS - Earnings per share growth rate in current year|Earnings growth forecast for next year Codexis, Inc.
Comprehensive company analysis:Codexis, Inc., CDXS
A defensive portfolio is constructed based on rigorous fundamental screening that eliminates emotional market interpretations. This indicator captures the average mathematical expectation of analysts regarding the change in earnings per share for the coming year. For Codexis, Inc. (CDXS), this forecast reflects the commercial potential of the CodeEvolver platform for creating custom proteins. Assessing the forward EPS trend helps determine the degree of expert optimism regarding the scaling of the business.
Competing companies
Expected earnings per share growth for next year TEM|QGEN: Expected earnings per share trend next year|Earnings growth forecast for next year IONS|Consensus forecast of earnings per share growth for next year repligen.com|Net earnings per share growth forecast for next year Avidity Biosciences, Inc. RNA|CRSP: Projected earnings per share growth rate for next year|Sema4 - Earnings growth forecast for next year|Ultragenyx Corp (RARE) - Expected earnings per share growth for next year|BEAM (Beam Therapeutics Inc.) - Expected earnings per share growth for next year|SRPT - Consensus forecast of earnings per share growth for next year|TWST (Twist Bioscience, Inc.) - Earnings growth forecast for next year|Expected earnings per share growth for next year 10x Genomics Inc (TXG)|Earnings growth forecast for next year NTLA|Stoke Corp - Projected earnings per share growth rate for next year|BioLife Solutions, Inc. - Expected earnings per share growth for next year|WVE: Projected earnings per share growth rate for next year|MAZE - Net earnings per share growth forecast for next year|Consensus forecast of earnings per share growth for next year Sionna Therapeutics, Inc. SION|PRME: Earnings growth forecast for next year|Projected earnings per share growth rate for next year TSHA|Net earnings per share growth forecast for next year uniQure N.V.|Projected earnings per share growth rate for next year MGTX (meiragtx.com)|Earnings growth forecast for next year RGNX|Earnings growth forecast for next year Solid Biosciences Inc (SLDB)|Earnings growth forecast for next year OCGN (Ocugen Corp)|PACB - Expected earnings per share growth for next year|BNTC - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year designtx.com|RCKT: Earnings growth forecast for next year|Projected earnings per share growth rate for next year FDMT|LXEO (Lexeo Therapeutics Inc.) - Earnings growth forecast for next year|Expected net earnings per share growth next year Korro Bio, Inc KRRO|Expected earnings per share growth for next year EDIT (Editas Medicine, Inc.)|silence-therapeutics.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year PRQR (ProQR Therapeutics)|Consensus forecast of earnings per share growth for next year Sangamo Therapeutics Inc. (SGMO)|NAUT - Net earnings per share growth forecast for next year|Consensus forecast of earnings per share growth for next year Metagenomi Therapeutics MGX|DTIL (Precision BioSciences, Inc.) - Expected earnings per share growth for next year|Generation Bio - Expected earnings per share trend next year|BOLD (Boundless Bio) - Earnings growth forecast for next year|Exicure Corp (XCUR) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Imunon, Inc. (IMNN)|phiopharma.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year MBIO (Mustang Bio)|RNAZ - Expected earnings per share growth for next year|BNGO: Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year Applied DNA Sciences Inc APDN|BLUE: Earnings growth forecast for next year|Expected earnings per share growth for next year ImmunoPrecise Antibodies Ltd.|OMGA (Omega Therapeutics) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year OMIC (singulargenomics.com)|Expected earnings per share growth for next year RGLS (Regulus Therapeutics Inc.)|Syros Pharmaceuticals Inc. - Projected earnings per share growth rate for next year|Net earnings per share growth forecast for next year Codex DNA TBIO|Consensus forecast of earnings per share growth for next year TRACON Pharmaceuticals, Inc (TCON)|Unity Biotechnology - Earnings growth forecast for next year
